280 related articles for article (PubMed ID: 19840825)
21. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
[TBL] [Abstract][Full Text] [Related]
22. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
[TBL] [Abstract][Full Text] [Related]
23. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
[TBL] [Abstract][Full Text] [Related]
24. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
25. Microneedle-based vaccines.
Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
[TBL] [Abstract][Full Text] [Related]
26. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
[TBL] [Abstract][Full Text] [Related]
27. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
[TBL] [Abstract][Full Text] [Related]
28. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
[TBL] [Abstract][Full Text] [Related]
29. Improved influenza vaccination in the skin using vaccine coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
Vaccine; 2009 Nov; 27(49):6932-8. PubMed ID: 19761836
[TBL] [Abstract][Full Text] [Related]
30. Transdermal influenza immunization with vaccine-coated microneedle arrays.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
[TBL] [Abstract][Full Text] [Related]
31. Long-term stability of influenza vaccine in a dissolving microneedle patch.
Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
[TBL] [Abstract][Full Text] [Related]
32. Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants.
Shin Y; Kim J; Seok JH; Park H; Cha HR; Ko SH; Lee JM; Park MS; Park JH
Sci Rep; 2022 Jul; 12(1):12189. PubMed ID: 35842468
[TBL] [Abstract][Full Text] [Related]
33. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
[TBL] [Abstract][Full Text] [Related]
34. Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Jacob J; Prausnitz MR; Compans RW; Skountzou I
J Infect Dis; 2011 Aug; 204(4):582-91. PubMed ID: 21685355
[TBL] [Abstract][Full Text] [Related]
35. Dissolving polymer microneedle patches for influenza vaccination.
Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
[TBL] [Abstract][Full Text] [Related]
36. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
37. Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles.
Choi HJ; Song JM; Bondy BJ; Compans RW; Kang SM; Prausnitz MR
PLoS One; 2015; 10(7):e0134431. PubMed ID: 26230936
[TBL] [Abstract][Full Text] [Related]
38. Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.
Kim YC; Quan FS; Song JM; Vunnava A; Yoo DG; Park KM; Compans RW; Kang SM; Prausnitz MR
Procedia Vaccinol; 2010; 2(1):15-19. PubMed ID: 21528098
[TBL] [Abstract][Full Text] [Related]
39. Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.
Tao W; Hurst BL; Shakya AK; Uddin MJ; Ingrole RS; Hernandez-Sanabria M; Arya RP; Bimler L; Paust S; Tarbet EB; Gill HS
Antiviral Res; 2017 May; 141():62-72. PubMed ID: 28161578
[TBL] [Abstract][Full Text] [Related]
40. Patchless administration of canine influenza vaccine on dog's ear using insertion-responsive microneedles (IRMN) without removal of hair and its in vivo efficacy evaluation.
Choi IJ; Na W; Kang A; Ahn MH; Yeom M; Kim HO; Lim JW; Choi SO; Baek SK; Song D; Park JH
Eur J Pharm Biopharm; 2020 Aug; 153():150-157. PubMed ID: 32544527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
